Furthermore, targeting GRK5 activity presents a novel approach to managing HF [128]; for example, strategies include the use of GRK5-specific small molecule interfering RNA (RNAi) delivered to the heart via adenovirus or the application of a specific peptide inhibitor to obstruct GRK5 activity within the heart. Here, GRK5 is linked to hydrops fetalis.